Pharmacokinetic Models: Comparison and Selection Criterion
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacodynamic Models: Overview
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 17, 2026

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Felipe Mattioni Maturana1, Federico Y Fontana2, Silvia Pogliaghi2
1Faculty of Kinesiology, University of Calgary, Canada.
Accurate critical power (CP) and work above CP (W') estimation in cyclists requires careful model selection and trial duration. The 3-parameter hyperbolic model (CP3-hyp) proved most accurate, with models using two trials between 12-20 minutes also showing good agreement.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: